Evidence map›Paper›PMID 28823716›Full record

ArticleActa biomaterialia2017

Tissue-specific extracellular matrix promotes myogenic differentiation of human muscle progenitor cells on gelatin and heparin conjugated alginate hydrogels.

Hualin Yi, Steven Forsythe, Yunyan He, Qiang Liu, Geng Xiong, Shicheng Wei, Guodong Li, Anthony Atala, Aleksander Skardal, Yuanyuan Zhang

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Skeletal Muscle Tissue Engineering: From Tissue Regeneration to Biorobotics.Cyborg and bionic systems (Washington, D.C.) · 2025
    Review
  4. Article
  5. Urine-derived stem cells genetically modified with IGF1 improve muscle regeneration.American journal of clinical and experimental urology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Porous biomaterial scaffolds for skeletal muscle tissue engineering.Frontiers in bioengineering and biotechnology · 2023
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Heparin and Derivatives for Advanced Cell Therapies.International journal of molecular sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Hualin YiKey Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China; Wake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA.
Steven ForsytheWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA.
Yunyan HeWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA.
Qiang LiuWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA.
Geng XiongWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA.
Shicheng WeiAcademy for Advanced Interdisciplinary Studies, Peking University, Laboratory of Biomaterials and Regenerative Medicine, Beijing, China.
Guodong LiDepartment of Clinical Translational Research, Singapore General Hospital, 20 College Road, Academia, Singapore.
Anthony AtalaWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA; Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, USA.
Aleksander SkardalWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA; Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, USA; Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA. Electronic address: askardal@wakehealth.edu.
Yuanyuan ZhangWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC, USA; Hypertension and Vascular Research Center, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA; Center on Diabetes, Obesity, and Metabolism, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA. Electronic address: yzhang@wakehealth.edu.
Forest Institute · USPeking University · CNSingapore General Hospital · SG

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Stem Cell Therapy Combined with Growth Factors for Stress Urinary IncontinenceR56DK100669 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ZHANG, YUANYUAN NO · 2014 to 2014
$116k
NCATS NIH HHS UL1 TR001420NIDDK NIH HHS R56 DK100669
6 · The paper itself

Abstract

Myogenic differentiation, cell fusion, and myotube formation of skeletal muscle progenitor cells (SMPCs) have key roles during skeletal muscle development and repair. However, after isolation from living tissue and transition to culture dishes, SMPCs gradually lose their function and stop propagating due to the absence of extracellular matrix (ECM). Despite encouraging results of experiments using ECM components in cell culture for maintenance and propagation of some tissue types, the benefits of this approach on SMPC culture are limited, because the bioactive molecules and proteins instantly release and are degraded during culture. In this study, we developed a novel approach to enhance the proliferation and differentiation of human skeletal muscle progenitor cells (hSMPCs) in vitro with skeletal muscle ECM in combination with a modified alginate hydrogel conjugated with gelatin and heparin (Alg-G-H) as a substrate. This Alg-G-H substrate, together with skeletal muscle ECM, significantly enhanced cell expansion, differentiation, and maturation of hSMPCs compared with individual substrata (i.e. gelatin, Matrigel®, or ECM alone). In Western-blot and immunocytochemical analyses, the Alg-G-H-ECM predominantly enhanced expression of skeletal myogenesis markers (MyoD, Myf5, Myogenin, Desmin and Myosin) and myotube formation in hSMPCs. This study demonstrated that combining Alg-G-H substrates with skeletal muscle ECM modulated homeostasis of cell proliferation, differentiation, and maturation of hSMPCs by releasing signaling molecules and growth factors. This technique could be a cost-effective tool for in vitro skeletal muscle cell differentiation and maturation, with potential applications in tissue regeneration and drug development. STATEMENT OF SIGNIFICANCE: Alginate based biomaterials are commonly used in tissue engineering and regenerative medicine field, however, the inefficient sequestration of growth factors restricted its utilization. In this study, a novel alginate based substrates was produced covalently modified with gelatin and heparin, in order to capture more effective cytokines and proteins in the culture milieu, keep homeostasis for cell survival and tissue regeneration with growth factor sequestration and long-term release capacities. Combining with skeletal muscle derived ECM, the modified Alginate-Gelatin-Heparin gel could most effectively mimic the tissue specific microenvironment to support skeletal muscle progenitor cells proliferation, differentiation and myotube formation. Additionally, the economical and practical features will make it more promising in high-throughput application for regenerative medicine research.

Indexed as

Cell DifferentiationMuscle DevelopmentAlginatesAnimalsExtracellular MatrixGelatinGlucuronic AcidHeparinHexuronic AcidsHumansHydrogelsMyoblastsOrgan SpecificitySwineAlginatesGelatinGlucuronic AcidHeparinHexuronic AcidsHydrogelsAlginateGelatinHeparinMyogenesisSkeletal muscle derived extracellular matrixSkeletal muscle progenitor cells

Identifiers

PMID28823716
PMCPMC8151673
OpenAlexW2749597777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.